Liver Diseases
Biochemical Mechanisms and New Therapeutic Insights
- Publisher's listprice GBP 115.00
-
58 201 Ft (55 430 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 5 820 Ft off)
- Discounted price 52 381 Ft (49 887 Ft + 5% VAT)
58 201 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher CRC Press
- Date of Publication 27 May 2025
- ISBN 9781578084005
- Binding Hardback
- No. of pages264 pages
- Size 276x219 mm
- Weight 453 g
- Language English 700
Categories
Short description:
This book presents information summarizing the current understanding of a range of liver diseases, and reviews some key diagnostic and therapeutic advances.
MoreLong description:
This book presents state-of-art information summarizing the current understanding of a range of liver diseases, and reviews some key diagnostic and therapeutic advances. The book is a collection of selected clinical and scientific topics divided into two volumes, each divided into two sections. The first volume treats the cellular, biochemical and immunological mechanisms underlying liver diseases; the second focuses on clinical liver disease pathophysiology and related diagnostics and therapeutic insights. It is hoped that the target readers - hepatologists, clinicians, researchers and cademicians - will be exposed to new ideas, and subjects beyond their own scientific disciplines. In addition, students and all those who wish to enlarge their knowledge of advances in the field of liver diseases will find this book a good source of information.
MoreTable of Contents:
VOLUME 1: LIVER DISEASES: PATHWAYS, MEDIATORS AND REGULATION : Section I: Liver Diseases: Mediators and Regulation: Ubiquitin - Proteasome Pathway in the Pathogenesis of Liver Disease; Bardag-Gorce; Collagen Gene Regulation in the Hepatic Stellate Cell; Rippe; CYP2F1-Biochemical and Toxicological Aspects and Role in Alcohol-induced Liver Injury; Cederbaum; Alcohol and Methyl Transfer: Implications for Alcohol-Related Hepatocarcinogenesis; Menthionine Adenosyltransferase and S-adenosylmethionine in Liver Health and Disease; Acetone Metabolism in the Liver; Oxidative Stress and Liver Fibrosis: From Liver Injury to Modulation of Cell Signalling and Response; Role of Nitric Oxide in Liver Disorders; Renin-Angiotensin System in Liver Fibrosis Section II: Immunological Basis of Liver Injury: Cell and Molecular Mechanisms in the Development of Chronic Liver Inflammation; Role of Activated Macrophages in Liver Disease; Investigations into Basis for Immune Recognition of Cellular Targets in Primary Biliary Cirrhosis; Cross Talk of Hepatocytes and Nonparenchymal Liver Cells in Physiology and Pathology: Monoxides and Eicosanoids; Activity of Cytokines in Chronic HCV Infection and Influence of Antiviral Drugs; Role of Chemokines in Liver Pathophysiology VOLUME 2: CLINICAL LIVER DISEASES: PATHOPHYSIOLOGY, DIAGNOSTIC AND THERAPEUTIC INSIGHTS: Section III: Clinical Liver Disease Pathophysiology: Nonalcoholic Fatty Liver Diseases: Clinical and Pathophysiological Features; Genetic Basis of Hepatocellular Cancer; Haemochromatosis: Recent Advances; Pathophysiology of Cirrhotic Ascites: Recent Advances; Cryptogenic Hepatitis; HIV-1 and the Liver; Cell Death by Necrosis: Mechanisms and Interception in the Liver; Fulminant Hepatic Failure: Etiology, Pathogenesis, and Treatment Section IV: Therapeutic and Diagnostic Insights: Advances in Biology and Therapy of Hepatitis B Virus Infection; Hepatitis C Virus: Molecular Virology and Therapeutic Targets; Drug Targeting to Hepatic Stellate Cel
More
